Prab: CSV import

2025-03-17T02:54:54Z

CSV import

← Older revision		Revision as of 02:54, 17 March 2025
Line 51:		Line 51:
	{{medicine-stub}}		{{medicine-stub}}
	{{No image}}		{{No image}}
			__NOINDEX__

Prab: CSV import

2025-02-10T05:17:25Z

CSV import

← Older revision		Revision as of 05:17, 10 February 2025
Line 50:		Line 50:

	{{medicine-stub}}		{{medicine-stub}}
			{{No image}}

Prab: CSV import

2024-08-07T02:58:33Z

CSV import

New page

'''ATC code J02''' is a section of the [[Anatomical Therapeutic Chemical Classification System]] (ATC), which is used for the classification of drugs and other medical products. This specific code pertains to [[antimycotics]] for systemic use. The ATC system is maintained by the [[World Health Organization]] (WHO) and is widely used for drug classification in both clinical and research settings.

== Classification ==
The ATC code J02 is divided into several subcategories, each representing a different type of systemic antimycotic. These subcategories include:

* '''J02A''' - [[Antimycotics for systemic use]]
** '''J02AA''' - [[Antibiotics]] for systemic use
** '''J02AB''' - [[Imidazole]] derivatives
** '''J02AC''' - [[Triazole]] derivatives
** '''J02AX''' - Other antimycotics for systemic use

== J02A: Antimycotics for Systemic Use ==
This category includes drugs that are used to treat systemic fungal infections. These infections can affect various parts of the body, including the [[bloodstream]], [[lungs]], and other internal organs.

=== J02AA: Antibiotics for Systemic Use ===
This subcategory includes antibiotics that are specifically used to treat fungal infections. These drugs are distinct from antibiotics used to treat bacterial infections.

=== J02AB: Imidazole Derivatives ===
Imidazole derivatives are a class of antifungal drugs that inhibit the synthesis of [[ergosterol]], an essential component of fungal cell membranes. Examples include [[ketoconazole]] and [[miconazole]].

=== J02AC: Triazole Derivatives ===
Triazole derivatives are another class of antifungal drugs that also inhibit ergosterol synthesis. They are generally more effective and have fewer side effects compared to imidazole derivatives. Examples include [[fluconazole]] and [[itraconazole]].

=== J02AX: Other Antimycotics for Systemic Use ===
This subcategory includes other types of systemic antifungal drugs that do not fall into the previous categories. Examples include [[amphotericin B]] and [[flucytosine]].

== Clinical Use ==
Systemic antimycotics are used to treat a variety of fungal infections, including [[candidiasis]], [[aspergillosis]], and [[cryptococcosis]]. These infections can be life-threatening, especially in immunocompromised patients, such as those with [[HIV/AIDS]] or undergoing [[chemotherapy]].

== Side Effects ==
The side effects of systemic antimycotics can vary depending on the specific drug and the patient's overall health. Common side effects include [[nausea]], [[vomiting]], and [[liver toxicity]]. Long-term use can also lead to [[resistance]].

== See Also ==
* [[ATC code J]]
* [[Antifungal]]
* [[Systemic infection]]
* [[World Health Organization]]

== References ==
{{Reflist}}

== External Links ==
{{ATC code J02}}

[[Category:ATC codes]]
[[Category:Antifungals]]
[[Category:Pharmacology]]
[[Category:World Health Organization]]
[[Category:Medicine]]

{{medicine-stub}}

ATC code J02 - Revision history

Prab: CSV import

Prab: CSV import

Prab: CSV import